{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:48:44Z","timestamp":1788929324094,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12171396"],"award-info":[{"award-number":["12171396"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12071381"],"award-info":[{"award-number":["12071381"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171152"],"award-info":[{"award-number":["32171152"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mathematical Biosciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mbs.2025.109568","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:39:35Z","timestamp":1762958375000},"page":"109568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Modeling covalently closed circular DNA dynamics in assessing chronic hepatitis B prognosis"],"prefix":"10.1016","volume":"390","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5838-3873","authenticated-orcid":false,"given":"Qiulin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3369-0928","authenticated-orcid":false,"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2586-094X","authenticated-orcid":false,"given":"Zaitang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6092-9124","authenticated-orcid":false,"given":"Guangyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6787-5018","authenticated-orcid":false,"given":"Kaifa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4741-7789","authenticated-orcid":false,"given":"Wendi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mbs.2025.109568_bib0001","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/hep.26549","article-title":"Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients","volume":"58","author":"Jeng","year":"2013","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.mbs.2025.109568_bib0002","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/gutjnl-2013-305517","article-title":"HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability","volume":"63","author":"Kim","year":"2014","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.mbs.2025.109568_bib0003","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"European association for the study of the liver, EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.mbs.2025.109568_bib0004","first-page":"1425","article-title":"Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)","volume":"11","author":"You","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"3","key":"10.1016\/j.mbs.2025.109568_bib0005","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(86)90602-1","article-title":"Formation of the pool of covalently closed circular viral DNA in hepadna virus infected cells","volume":"47","author":"Tuttleman","year":"1986","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.mbs.2025.109568_bib0006","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection","volume":"71","author":"Raimondo","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mbs.2025.109568_bib0007","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/S0140-6736(18)31865-8","article-title":"Chronic hepatitis B virus infection","volume":"392","author":"Seto","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.mbs.2025.109568_bib0008","first-page":"241","article-title":"RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg","volume":"409","author":"Wooddell","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.mbs.2025.109568_bib0009","first-page":"815","article-title":"Quantitative analyses of intrahepatic HBV cccDNA and serum HBsAg in 54 patients with chronic hepatitis B","volume":"19","author":"Li","year":"2011","journal-title":"Chin. J. Hepatol."},{"issue":"2","key":"10.1016\/j.mbs.2025.109568_bib0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/jcm11020387","article-title":"Use of a deep learning approach for the sensitive prediction of hepatitis B surface antigen levels in inactive carrier patients","volume":"11","author":"Kamimura","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.mbs.2025.109568_bib0011","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12879-023-08443-1","article-title":"Establishment of a multi-parameter prediction model for the functional cure of HBeAg-negative chronic hepatitis B patients treated with pegylated interferon-\u03b1 and decision process based on response-guided therapy strategy,","volume":"23","author":"Tang","year":"2023","journal-title":"BMC Infect. Dis."},{"issue":"10","key":"10.1016\/j.mbs.2025.109568_bib0012","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1136\/gutjnl-2024-332182","article-title":"High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy","volume":"73","author":"Fan","year":"2024","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.mbs.2025.109568_bib0013","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jhep.2024.03.022","article-title":"ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in chinese patients with chronic hepatitis B","volume":"81","author":"Leung","year":"2024","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.mbs.2025.109568_bib0014","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s12072-024-10648-8","article-title":"Predictors of HBsAg seroclearance in patients with chronic HBV infection treated with pegylated interferon-\u03b1: a systematic review and meta-analysis","volume":"18","author":"Jiang","year":"2024","journal-title":"Hepatol. Int."},{"issue":"4","key":"10.1016\/j.mbs.2025.109568_bib0015","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/s12072-024-10666-6","article-title":"Predictive models for functional cure in patients with CHB receiving PEG-IFN therapy based on HBsAg quantification through meta-analysis","volume":"18","author":"Zhang","year":"2024","journal-title":"Hepatol. Int."},{"issue":"4","key":"10.1016\/j.mbs.2025.109568_bib0016","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/gutjnl-2014-307237","article-title":"Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study","volume":"64","author":"Seto","year":"2015","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.mbs.2025.109568_bib0017","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.cgh.2016.03.024","article-title":"Association between serum level of hepatitis B surface antigen at end of entecavir therapy and risk of relapse in e antigen negative patients","volume":"14","author":"Hsu","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.mbs.2025.109568_bib0018","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.22586","article-title":"Modeling complex decay profiles of hepatitisB virus during antiviral therapy","volume":"49","author":"Dahari","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.mbs.2025.109568_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1011238","article-title":"Multiscale modeling of HBV infection integrating intra- and intercellular viral propagation to analyze extracellular viral markers","volume":"20","author":"Kitagawa","year":"2024","journal-title":"PLoS Comput. Biol."},{"issue":"6","key":"10.1016\/j.mbs.2025.109568_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00285-024-02096-7","article-title":"Dynamical analysis of a general delayed HBV infection model with capsids and adaptive immune response in presence of exposed infected hepatocytes","volume":"88","author":"Foko","year":"2024","journal-title":"J. Math. Biol."},{"issue":"17","key":"10.1016\/j.mbs.2025.109568_bib0021","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jama.2018.3795","article-title":"Chronic hepatitis B infection a review","volume":"319","author":"Tang","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.mbs.2025.109568_bib0022","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jtbi.2014.11.020","article-title":"In silico single cell dynamics of hepatitis B virus infection and clearance","volume":"366","author":"Murray","year":"2015","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.mbs.2025.109568_bib0023","first-page":"1220","article-title":"Global sensitivity analysis of a single-cell HBV model for viral dynamics in the liver","volume":"6","author":"Ali","year":"2021","journal-title":"Infect. Dis. Modell."},{"issue":"6","key":"10.1016\/j.mbs.2025.109568_bib0024","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jhep.2018.08.012","article-title":"Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels","volume":"69","author":"Ko","year":"2018","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.mbs.2025.109568_bib0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0025-5564(97)10015-3","article-title":"Modeling and analysis of a marine bacteriophage infection","volume":"149","author":"Beretta","year":"1998","journal-title":"Math. Biosci."},{"issue":"S1","key":"10.1016\/j.mbs.2025.109568_bib0026","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0025-5564(02)00108-6","article-title":"Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission","volume":"180","author":"Driessche","year":"2002","journal-title":"Math. Biosci."},{"issue":"4","key":"10.1016\/j.mbs.2025.109568_bib0027","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00178324","article-title":"On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations","volume":"28","author":"Diekmann","year":"1990","journal-title":"J. Math. Biol."},{"issue":"1","key":"10.1016\/j.mbs.2025.109568_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.mbs.2025.109568_bib0029","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/apt.16067","article-title":"Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis","volume":"52","author":"Sonneveld","year":"2020","journal-title":"Aliment. Pharmacol. Therap."},{"issue":"4","key":"10.1016\/j.mbs.2025.109568_bib0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11222-006-9438-0","article-title":"DRAM: efficient adaptive MCMC","volume":"16","author":"Haario","year":"2006","journal-title":"Stat. Comput."},{"issue":"1","key":"10.1016\/j.mbs.2025.109568_bib0031","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hep.31240","article-title":"Rapid turnover of hepatitis B virus covalently closed circular DNA indicated by monitoring emergence and reversion of signature-mutation in treated chronic hepatitis B patients","volume":"73","author":"Huang","year":"2021","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.mbs.2025.109568_bib0032","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/jvh.13126","article-title":"Roadmap to functional cure of chronic hepatitis B: an expert consensus","volume":"26","author":"Ning","year":"2019","journal-title":"J. Viral Hepat."},{"issue":"5","key":"10.1016\/j.mbs.2025.109568_bib0033","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s12072-019-09956-1","article-title":"Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the endeavor study","volume":"13","author":"Wu","year":"2019","journal-title":"Hepatol. Int."},{"issue":"6","key":"10.1016\/j.mbs.2025.109568_bib0034","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hsr2.932","article-title":"Interleukin-2 promotes pegylated interferon-\u03b1 for hepatitis B surface antigen loss: a retrospective pragmatic clinical study at the fourth affiliated hospital of Zhejiang University medical college","volume":"5","author":"Qi","year":"2022","journal-title":"Health Sci. Rep."},{"issue":"5","key":"10.1016\/j.mbs.2025.109568_bib0035","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jhep.2011.06.006","article-title":"Hepatitis B surface antigen quantification: why and how to use it in 2011-a core group report","volume":"55","author":"Chan","year":"2011","journal-title":"J. Hepatol."},{"issue":"S1","key":"10.1016\/j.mbs.2025.109568_bib0036","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0168-8278(09)60919-3","article-title":"On treatment monitoring of HBsAg levels to predict response to peginterferon alfa-2a in patients with HBeAg-positive chronic hepatitis B","volume":"50","author":"Lau","year":"2009","journal-title":"J. Hepatol."},{"issue":"11\u201312","key":"10.1016\/j.mbs.2025.109568_bib0037","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1365-2036.2010.04474.x","article-title":"Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B","volume":"32","author":"Chan","year":"2010","journal-title":"Aliment. Pharmacol. Therap."},{"issue":"10","key":"10.1016\/j.mbs.2025.109568_bib0038","first-page":"2159","article-title":"Hepatitis B virus core-related antigen: a promising new serum marker for hepatitis B virus","volume":"35","author":"Cheng","year":"2019","journal-title":"J. Clin. Hepatol."},{"issue":"10","key":"10.1016\/j.mbs.2025.109568_bib0039","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/jvh.13117","article-title":"Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis B","volume":"26","author":"Campenhout","year":"2019","journal-title":"J. Viral Hepat."},{"issue":"4","key":"10.1016\/j.mbs.2025.109568_bib0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jhep.2018.11.030","article-title":"Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients","volume":"70","author":"Testoni","year":"2019","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.mbs.2025.109568_bib0041","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/17513750701769873","article-title":"Dynamics of a delay differential equation model of hepatitis B virus infection","volume":"2","author":"Gourrley","year":"2008","journal-title":"J. Biol.l Dyn."},{"key":"10.1016\/j.mbs.2025.109568_bib0042","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mbs.2015.05.001","article-title":"Global dynamics of a delayed within-host viral infection model with both virus-to-cell and cell-to-cell transmissions","volume":"270","author":"Yang","year":"2015","journal-title":"Math. Biosci."},{"issue":"1","key":"10.1016\/j.mbs.2025.109568_bib0043","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1137\/23M154546X","article-title":"Dynamics on hepatitis B virus infection in vivo with interval delay","volume":"23","author":"Zhong","year":"2024","journal-title":"SIAM J. Appl. Dyn. Syst."},{"key":"10.1016\/j.mbs.2025.109568_bib0044","article-title":"Delayed hepatitis B epidemic model with stochastic analysis","volume":"146","author":"Din","year":"2021","journal-title":"Solitons Fract."},{"issue":"2","key":"10.1016\/j.mbs.2025.109568_bib0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00332-022-09883-w","article-title":"Analysis of a stochastic HBV infection model with DNA containing capsids and virions","volume":"33","author":"Liu","year":"2023","journal-title":"J. Nonlinear Sci."},{"key":"10.1016\/j.mbs.2025.109568_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.aml.2024.109234","article-title":"Stochastic dynamics on HBV infection in vivo with interval delay","volume":"158","author":"Zhong","year":"2024","journal-title":"Appl. Math. Lett."}],"container-title":["Mathematical Biosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025556425001944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025556425001944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T22:24:06Z","timestamp":1766096646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025556425001944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":46,"alternative-id":["S0025556425001944"],"URL":"https:\/\/doi.org\/10.1016\/j.mbs.2025.109568","relation":{},"ISSN":["0025-5564"],"issn-type":[{"value":"0025-5564","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling covalently closed circular DNA dynamics in assessing chronic hepatitis B prognosis","name":"articletitle","label":"Article Title"},{"value":"Mathematical Biosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mbs.2025.109568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109568"}}